Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
Join the club for FREE to access the whole archive and other member benefits.
Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Fast, free MIT AI predicts molecular binding strength in seconds—no license needed
Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Click on resource name for more details.
Alex Telford on AI, digital twins, and biotech’s biggest questions
LabGenius: Cutting through AI hype in drug development
Elise de Reus explores how their platform is putting tech into biotech
Alex Zhavoronkov presented methylation clocks and AI models as groundbreaking tools
No blog posts found!